Rapid and Effective Elimination of Myoglobin with CytoSorb® Hemoadsorber in Patients with Severe Rhabdomyolysis

被引:8
|
作者
Albrecht, Frederic [1 ,2 ]
Schunk, Stefan [2 ,3 ]
Fuchs, Maren [1 ,2 ]
Volk, Thomas [1 ,2 ]
Geisel, Juergen [2 ,4 ]
Fliser, Danilo [2 ,3 ]
Meiser, Andreas [1 ,2 ]
机构
[1] Saarland Univ, Med Ctr, Dept Anesthesiol Intens Care & Pain Therapy, Homburg, Germany
[2] Saarland Univ, Fac Med, Homburg, Germany
[3] Saarland Univ, Med Ctr, Dept Internal Med Nephrol & Hypertens 4, Homburg, Germany
[4] Saarland Univ, Med Ctr, Dept Clin Chem & Lab Med, Homburg, Germany
关键词
Acute kidney injury; Continuous renal replacement therapy; Hemoadsorber; Myoglobin; Renal replacement therapy; Rhabdomyolysis; HEMODIAFILTRATION; REMOVAL;
D O I
10.1159/000534479
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Rhabdomyolysis is characterized by destruction of muscle fibers by various causes and is diagnosed by increased creatine kinase concentrations in the blood. Myoglobin released into the blood may cause acute kidney injury. In this randomized controlled study, we hypothesized that myoglobin elimination would be faster when a hemoadsorber was added to a continuous veno-venous hemodialysis (CVVHD). Methods: Four patients in the control group received CVVHD with a high cut-off hemofilter using high blood and dialysate flows for 48 h. Four patients in the CytoSorb group received the same treatment, but in addition, the hemoadsorber CytoSorb (R) was inserted in front of the hemofilter and replaced once after 24 h. Blood samples were drawn simultaneously before (pre) and after (post) the hemofilter or else the hemoadsorber, after 5 and 30 min, as well as after 2, 4, 8, and 24 h. All measurements were repeated the next day after the hemoadsorber had been renewed in the CytoSorb group. Primary outcome was the area under the curve (AUC) of the relative myoglobin concentrations as percent of baseline. To evaluate the efficacy of myoglobin removal, relative reductions in myoglobin concentrations during one passage through each device at each time point were calculated. Results: Patients in the CytoSorb group had a significantly lower AUC during the first 24 h (42 +/- 10% vs. 63 +/- 6%, p = 0.029) as well as during the observation period of 48 h (26 +/- 7% vs. 51 +/- 12%, p = 0.029). The relative reductions for myoglobin were considerably higher in the CytoSorb group compared to the control group during the first 8 h. Conclusion: Myoglobin concentrations declined considerably faster when CytoSorb was added to a CVVHD. When compared to a high-cut-off hemofilter, efficacy of CytoSorb in myoglobin elimination was much better. Because of saturation after 8-12 h an exchange may be necessary.(c) 2023 The Author(s).Published by S. Karger AG, Basel
引用
收藏
页码:88 / 95
页数:8
相关论文
共 45 条
  • [21] Prognostic value, kinetics and effect of CVVHDF on serum of the myoglobin and creatine kinase in critically ill patients with rhabdomyolysis
    Mikkelsen, TS
    Toft, P
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2005, 49 (06) : 859 - 864
  • [22] Risk factors for severe acute kidney injury among patients with rhabdomyolysis
    Yang, Jia
    Zhou, Jiaojiao
    Wang, Xin
    Wang, Siwen
    Tang, Yi
    Yang, Lichuan
    BMC NEPHROLOGY, 2020, 21 (01)
  • [23] Risk factors for severe acute kidney injury among patients with rhabdomyolysis
    Jia Yang
    Jiaojiao Zhou
    Xin Wang
    Siwen Wang
    Yi Tang
    Lichuan Yang
    BMC Nephrology, 21
  • [24] Clinical effects of hemoadsorption with CytoSorb® in patients with severe acute pancreatitis: A case series
    Tomescu, Dana
    Popescu, Mihai
    David, Corina
    Dima, Simona
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2019, 42 (04) : 190 - 193
  • [25] The Association Between Illicit Drug Use and the Duration of Renal Replacement Therapy in Patients With Acute Kidney Injury From Severe Rhabdomyolysis
    Lim, Andy K. H.
    Azraai, Meor
    Pham, Jeanette H.
    Looi, Wenye F.
    Bennett, Caitriona
    FRONTIERS IN MEDICINE, 2020, 7
  • [26] Short- and long-term renal outcomes following severe rhabdomyolysis: a French multicenter retrospective study of 387 patients
    Nelly Candela
    Stein Silva
    Bernard Georges
    Claire Cartery
    Thomas Robert
    Julie Moussi-Frances
    Eric Rondeau
    Jean-Michel Rebibou
    Laurence Lavayssiere
    Julie Belliere
    Thierry Krummel
    Céline Lebas
    Olivier Cointault
    Marion Sallee
    Stanislas Faguer
    Annals of Intensive Care, 10
  • [27] Short- and long-term renal outcomes following severe rhabdomyolysis: a French multicenter retrospective study of 387 patients
    Candela, Nelly
    Silva, Stein
    Georges, Bernard
    Cartery, Claire
    Robert, Thomas
    Moussi-Frances, Julie
    Rondeau, Eric
    Rebibou, Jean-Michel
    Lavayssiere, Laurence
    Belliere, Julie
    Krummel, Thierry
    Lebas, Celine
    Cointault, Olivier
    Sallee, Marion
    Faguer, Stanislas
    ANNALS OF INTENSIVE CARE, 2020, 10 (01)
  • [28] Dialyzer clearance of myoglobin with middle molecule filter and low blood flow CVVHD in patients with rhabdomyolysis-associated acute kidney injury
    I Leppanen
    T Ahonen
    J Tenhunen
    Critical Care, 17 (Suppl 2):
  • [29] SENSITIVE RAPID DETECTION OF MYOGLOBIN IN SERUM OF PATIENTS WITH MYOPATHY BY IMMUNOTURBIDIMETRIC ASSAY
    LOVECE, S
    KAGEN, LJ
    JOURNAL OF RHEUMATOLOGY, 1993, 20 (08) : 1331 - 1334
  • [30] Rhabdomyolysis associated with acute renal failure in patients with severe acute respiratory syndrome
    Chen, LL
    Hsu, CW
    Tian, YC
    Fang, JT
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (10) : 1162 - 1166